This wiki has undergone a migration to Confluence found Here
Difference between revisions of "2018-09-19 FMG concall"
Jump to navigation
Jump to search
(→Agenda) |
|||
| Line 51: | Line 51: | ||
***[http://wiki.hl7.org/index.php?title=EffectEvidenceSynthesis_FHIR_Resource_Proposal EffectEvidenceSynthesis] | ***[http://wiki.hl7.org/index.php?title=EffectEvidenceSynthesis_FHIR_Resource_Proposal EffectEvidenceSynthesis] | ||
***[http://wiki.hl7.org/index.php?title=RiskEvidenceSynthesis_FHIR_Resource_Proposal RiskEvidenceSynthesis] | ***[http://wiki.hl7.org/index.php?title=RiskEvidenceSynthesis_FHIR_Resource_Proposal RiskEvidenceSynthesis] | ||
| − | **UDI Pattern Publication Request | + | **[https://gforge.hl7.org/gf/download/trackeritem/18087/16917/HL7_Publication_Request_Template_OO_UDI_20180705.docx UDI Pattern Publication Request] |
**[https://gforge.hl7.org/gf/download/trackeritem/18060/16913/2018_September_HL7%20Publication%20Request%20-%20US%20Core_submitted.docx US Core Publication Request] | **[https://gforge.hl7.org/gf/download/trackeritem/18060/16913/2018_September_HL7%20Publication%20Request%20-%20US%20Core_submitted.docx US Core Publication Request] | ||
| − | **HL7 FHIR® Profile: Pharmacy; Medication, Release 2 Publication Request | + | **[https://gforge.hl7.org/gf/download/trackeritem/18086/16916/HL7%20Publication%20Request%20-%20US%20Meds%20-%20PDMP%20Update%201291%201.docx HL7 FHIR® Profile: Pharmacy; Medication, Release 2 Publication Request] |
*Discussion Topics | *Discussion Topics | ||
**[https://docs.google.com/document/d/1j_2HWER5p01_aZNK1GJZkdpQ05c3NRsiGo90V7W7RgE/edit#heading=h.ju6wcrgwyx2f Criteria for inclusion of profiles and valuesets in FHIR Core] - continued discussion | **[https://docs.google.com/document/d/1j_2HWER5p01_aZNK1GJZkdpQ05c3NRsiGo90V7W7RgE/edit#heading=h.ju6wcrgwyx2f Criteria for inclusion of profiles and valuesets in FHIR Core] - continued discussion | ||
Revision as of 19:19, 19 September 2018
| HL7 TSC FMG Meeting Minutes Location: |
Date: 2018-09-19 Time: 4:00 PM U.S. Eastern | |
| Chair: | Note taker(s): Anne W. | |
| Quorum = chair + 4 | yes/no | |||||
| Co chairs | David Hay | Lloyd McKenzie | ||||
| ex-officio | . | Wayne Kubick, CTO | ||||
| Members | Members | Members | Observers/Guests | ||||
| Hans Buitendijk | Brian Postlethwaite | Paul Knapp | Anne W., scribe | ||||
| Josh Mandel | John Moehrke | Brian Pech | |||||
| Grahame Grieve | . | ||||||
Agenda
- Roll Call
- Agenda Check
- Minutes from 2018-09-12_FMG_concall
- Action items
- Grahame to put together something to describe a desired level of BR&R community engagement in order to own Substance
- Lloyd to draft a process for approving technically breaking changes that are believed not to impact any implementations and submit for review by FMG, MnM and SGB
- Anne to contact BR&R cochairs/modeling facilitator to ask them to update the resource relationships section of AdverseEvent
- Hans to reach out to OO on BiologicallyDerivedProduct
- Brian Post to add RIM scope and boundaries section to ChargeItemDefinition
- Hans to check with OO, CDS, and CQI about DeviceUseStatement
- Hans to check with Lorraine about EntryDefinition
- Brian to update Invoice
- Hans to follow up with OO on ObservationDefinition2
- John to draft language regarding virtual Connectathons
- Review Items
- Discussion Topics
- Criteria for inclusion of profiles and valuesets in FHIR Core - continued discussion
- Criteria for what you need to have to claim that an IG is international in scope
- Criteria for inclusion of extensions in core vs. IGs to upcoming agenda
- Reports
- Connectathon management (David/Brian)
- SGB –
- MnM –
- FMG Liaisons –
- Process management
- Ballot Planning
- Ballot content review and QA process FHIR QA Guidelines
- AOB (Any Other Business)
Minutes
Next Steps
| Actions (Include Owner, Action Item, and due date) | |||
| Next Meeting/Preliminary Agenda Items |
Back to FHIR_Management_Group
© 2018 Health Level Seven® International
